Tae Won Kim Selected Research

Oxaliplatin (Eloxatin)

11/2022	Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07.
1/2022	Expression of SLC22A18 regulates oxaliplatin resistance by modulating the ERK pathway in colorectal cancer.
1/2022	CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer.
12/2021	Olaparib with or without bevacizumab or bevacizumab and 5-fluorouracil in advanced colorectal cancer: Phase III LYNK-003.
1/2021	Bevacizumab plus capecitabine as later-line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines.
10/2020	Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial.
9/2020	Evaluating waiting time with real-world health information in a high-volume cancer center.
11/2019	Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial.
10/2018	Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer.
4/2018	Oxaliplatin rechallenge in metastatic colorectal cancer patients after prior oxaliplatin treatment.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tae Won Kim Research Topics

Disease

120	Neoplasms (Cancer) 10/2022 - 04/2003
106	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 12/2004
39	Rectal Neoplasms (Rectal Cancer) 06/2022 - 12/2004
26	Neoplasm Metastasis (Metastasis) 07/2022 - 01/2006
20	Stomach Neoplasms (Stomach Cancer) 01/2017 - 10/2004
18	Colonic Neoplasms (Colon Cancer) 11/2022 - 12/2009
15	Adenocarcinoma 01/2018 - 01/2002
12	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2013 - 01/2006
11	Disease Progression 01/2022 - 02/2009
10	Microsatellite Instability 01/2022 - 09/2011
7	Fatigue 10/2022 - 05/2007
7	Pancreatic Neoplasms (Pancreatic Cancer) 12/2020 - 01/2002
6	Neutropenia 05/2015 - 11/2007
5	Sarcoma (Soft Tissue Sarcoma) 03/2022 - 07/2012
4	Nausea 10/2022 - 05/2007
4	Vomiting 10/2022 - 01/2005
4	Lymphatic Metastasis 01/2018 - 05/2011
4	Infections 01/2016 - 09/2007
3	Diarrhea 10/2022 - 07/2010
3	Pain (Aches) 05/2022 - 05/2007
3	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2012
3	Carcinogenesis 08/2018 - 06/2014
3	Hepatocellular Carcinoma (Hepatoma) 11/2015 - 08/2010
3	Exanthema (Rash) 06/2015 - 10/2011
3	Febrile Neutropenia 05/2015 - 07/2010
3	Hand-Foot Syndrome 04/2014 - 10/2004
3	Breast Neoplasms (Breast Cancer) 10/2013 - 08/2004
2	Constipation 10/2022 - 05/2007
2	Abdominal Pain (Pain, Abdominal) 10/2022 - 10/2015
2	Necrosis 06/2022 - 04/2014
2	Edema (Dropsy) 06/2022 - 10/2013
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021 - 06/2015
2	Melanoma (Melanoma, Malignant) 01/2021 - 12/2013
2	Anus Neoplasms (Anal Cancer) 12/2020 - 04/2003
2	Hypothyroidism 12/2019 - 09/2014
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2019 - 10/2018

Drug/Important Bio-Agent (IBA)

39	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2022 - 09/2007
38	Irinotecan (Camptosar)FDA LinkGeneric 11/2021 - 12/2004
37	Capecitabine (Xeloda)FDA Link 11/2021 - 07/2003
32	Fluorouracil (Carac)FDA LinkGeneric 12/2021 - 01/2002
26	Cetuximab (Erbitux)FDA Link 01/2022 - 09/2007
26	Bevacizumab (Avastin)FDA Link 12/2021 - 01/2009
19	Leucovorin (Folinic Acid)FDA Link 11/2021 - 01/2002
12	Biomarkers (Surrogate Marker)IBA 10/2022 - 12/2009
12	Imatinib Mesylate (Gleevec)FDA Link 04/2014 - 01/2006
11	Cisplatin (Platino)FDA LinkGeneric 10/2018 - 10/2004
10	Pharmaceutical PreparationsIBA 01/2022 - 12/2003
10	ErbB Receptors (EGF Receptor)IBA 10/2020 - 10/2011
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2004
9	Panitumumab (Vectibix)FDA Link 10/2020 - 05/2014
8	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2016
8	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 05/2004
8	Gemcitabine FDA Link 10/2018 - 01/2002
7	Monoclonal AntibodiesIBA 10/2020 - 01/2009
6	regorafenibIBA 12/2019 - 06/2015
6	XELOXIBA 07/2019 - 04/2008
6	Sunitinib (Sutent)FDA Link 01/2017 - 01/2009
5	Calcibiotic Root Canal SealerIBA 11/2022 - 01/2015
5	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2014
5	Carcinoembryonic AntigenIBA 01/2017 - 04/2010
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 05/2005
5	Docetaxel (Taxotere)FDA Link 06/2011 - 10/2004
4	Phosphotransferases (Kinase)IBA 01/2021 - 05/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2009
4	Simvastatin (Zocor)FDA LinkGeneric 07/2019 - 09/2009
4	trifluridine tipiracil drug combinationIBA 01/2019 - 05/2015
4	PlatinumIBA 04/2018 - 05/2005
4	Biological ProductsIBA 11/2017 - 07/2012
4	Histone Deacetylase InhibitorsIBA 04/2016 - 12/2010
3	MucinsIBA 06/2022 - 01/2013
3	ParaffinIBA 11/2021 - 05/2004
3	pembrolizumabIBA 01/2021 - 01/2020
3	VimentinIBA 09/2020 - 01/2016
3	thymidine kinase 1IBA 05/2015 - 08/2011
2	Immune Checkpoint InhibitorsIBA 10/2022 - 01/2019
2	sotorasibIBA 01/2022 - 01/2020
2	CateninsIBA 07/2021 - 01/2019
2	Inhibitor of Apoptosis ProteinsIBA 12/2020 - 09/2015
2	AntibodiesIBA 10/2020 - 01/2019
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 04/2016
2	Lipase (Acid Lipase)FDA Link 01/2020 - 06/2015
2	AntigensIBA 01/2020 - 09/2007
2	Alanine Transaminase (SGPT)IBA 01/2020 - 06/2015
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 12/2013

Therapy/Procedure

84	Drug Therapy (Chemotherapy) 05/2022 - 04/2003
48	Therapeutics 11/2022 - 12/2004
27	Chemoradiotherapy 04/2022 - 01/2007
15	Radiotherapy 07/2022 - 04/2003
13	Adjuvant Chemotherapy 01/2022 - 12/2004
8	Combination Drug Therapy (Combination Chemotherapy) 04/2018 - 10/2004
7	Neoadjuvant Therapy 12/2021 - 04/2010
4	Radiofrequency Ablation 07/2022 - 07/2011
4	Stents 12/2018 - 12/2007
3	Proctectomy 04/2022 - 10/2012
3	Palliative Care (Palliative Therapy) 01/2022 - 06/2008
3	Salvage Therapy 11/2017 - 10/2015
3	Gastrectomy 04/2015 - 01/2007
3	Aftercare (After-Treatment) 03/2015 - 10/2006
2	Osteotomy 11/2021 - 05/2013
2	Immunotherapy 01/2019 - 10/2016